NASDAQ:DXCM - DexCom Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $406.22
  • Forecasted Upside: 26.51 %
  • Number of Analysts: 19
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$321.09
▲ +5.22 (1.65%)
1 month | 3 months | 12 months
Get New DexCom Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DXCM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DXCM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$406.22
▲ +26.51% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for DexCom in the last 3 months. The average price target is $406.22, with a high forecast of $500.00 and a low forecast of $230.00. The average price target represents a 26.51% upside from the last price of $321.09.
Buy
The current consensus among 19 polled investment analysts is to buy stock in DexCom. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/2/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/31/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/29/2019
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/27/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/27/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/25/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/23/2020

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2020Piper SandlerReiterated RatingBuy$465.00Medium
i
Rating by Matthew O'Brien at Piper Sandler
10/28/2020Stifel NicolausLower Price TargetBuy$500.00 ➝ $475.00High
i
10/28/2020Canaccord GenuityLower Price TargetBuy$500.00 ➝ $475.00High
i
10/28/2020Raymond JamesLower Price TargetOutperform$450.00 ➝ $438.00High
i
10/28/2020Morgan StanleyLower Price TargetEqual Weight$428.00 ➝ $398.00High
i
10/2/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$420.00 ➝ $350.00High
i
7/29/2020UBS GroupBoost Price TargetNeutral$335.00 ➝ $400.00High
i
7/29/2020Morgan StanleyBoost Price TargetEqual Weight$377.00 ➝ $428.00Low
i
7/29/2020Canaccord GenuityBoost Price TargetBuy$435.00 ➝ $500.00Medium
i
7/29/2020Raymond JamesBoost Price TargetOutperform$395.00 ➝ $450.00Low
i
7/29/2020Stifel NicolausBoost Price TargetBuy$385.00 ➝ $500.00Low
i
7/29/2020SVB LeerinkBoost Price TargetEqual Weight ➝ Outperform$465.00 ➝ $485.00Medium
i
7/29/2020CitigroupBoost Price TargetBuy$440.00 ➝ $485.00Medium
i
7/29/2020Piper SandlerBoost Price TargetOverweight$450.00 ➝ $465.00Medium
i
7/28/2020OppenheimerInitiated CoverageBuy$360.00 ➝ $445.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
7/28/2020Bank of AmericaReiterated RatingBuy$500.00High
i
Rating by Travis Steed at Bank of America Co.
7/27/2020JPMorgan Chase & Co.Boost Price TargetOverweight$360.00 ➝ $450.00Medium
i
7/7/2020CowenBoost Price TargetPositive ➝ Outperform$430.00 ➝ $450.00Low
i
Rating by Ryan Blicker at Cowen Inc
6/17/2020Bank of AmericaBoost Price TargetBuy$375.00 ➝ $500.00Low
i
6/9/2020Raymond JamesBoost Price TargetOutperform$360.00 ➝ $395.00High
i
6/3/2020CitigroupBoost Price TargetAverage ➝ Buy$361.00 ➝ $440.00Medium
i
5/27/2020Piper SandlerBoost Price TargetOverweight$375.00 ➝ $450.00High
i
5/14/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$420.00Low
i
4/30/2020UBS GroupBoost Price TargetNeutral$275.00 ➝ $335.00Medium
i
4/29/2020GuggenheimBoost Price TargetBuy$385.00 ➝ $395.00High
i
Rating by Christopher Pasquale at Guggenheim
4/29/2020CitigroupBoost Price TargetBuy$330.00 ➝ $361.00High
i
4/29/2020Morgan StanleyBoost Price TargetEqual Weight$278.00 ➝ $377.00Medium
i
4/29/2020JPMorgan Chase & Co.Boost Price TargetOverweight$300.00 ➝ $360.00Medium
i
4/29/2020Stifel NicolausBoost Price TargetBuy$270.00 ➝ $385.00Medium
i
4/29/2020OppenheimerBoost Price TargetOutperform$305.00 ➝ $360.00High
i
4/29/2020CowenBoost Price TargetOutperform$300.00 ➝ $360.00High
i
Rating by Ryan Blicker at Cowen Inc
4/29/2020Robert W. BairdBoost Price TargetOutperform$296.00 ➝ $373.00High
i
4/29/2020Piper SandlerBoost Price TargetOverweight$300.00 ➝ $375.00High
i
4/29/2020BTIG ResearchReiterated RatingHoldHigh
i
4/27/2020Raymond JamesBoost Price TargetOutperform$288.00 ➝ $350.00Low
i
4/24/2020SVB LeerinkBoost Price TargetOutperform$316.00 ➝ $385.00Medium
i
3/27/2020Morgan StanleyBoost Price TargetEqual Weight$270.00 ➝ $278.00High
i
3/23/2020StephensLower Price TargetOverweight$300.00 ➝ $240.00Low
i
3/6/2020OppenheimerBoost Price TargetOutperform$285.00 ➝ $305.00Low
i
3/4/2020CitigroupInitiated CoverageBuy$330.00 ➝ $330.00Low
i
2/18/2020Morgan StanleyBoost Price TargetEqual Weight$225.00 ➝ $270.00High
i
2/14/2020Piper SandlerBoost Price Target$230.00 ➝ $300.00Low
i
2/14/2020CfraBoost Price TargetHold$205.00 ➝ $258.00High
i
2/14/2020OppenheimerBoost Price TargetOutperform$250.00 ➝ $285.00High
i
2/14/2020CowenReiterated RatingOutperform$250.00 ➝ $300.00High
i
Rating by Ryan Blicker at Cowen Inc
2/14/2020GuggenheimReiterated RatingBuy$245.00 ➝ $300.00High
i
2/14/2020Canaccord GenuityBoost Price TargetBuy$255.00 ➝ $300.00High
i
2/14/2020StephensBoost Price TargetOverweight$255.00 ➝ $300.00High
i
2/14/2020UBS GroupBoost Price TargetNeutral$250.00 ➝ $275.00High
i
2/14/2020Raymond JamesBoost Price TargetOutperform$258.00 ➝ $288.00High
i
2/14/2020Stifel NicolausBoost Price TargetBuy$250.00 ➝ $300.00High
i
1/7/2020CowenReiterated RatingBuy$250.00High
i
Rating by Ryan Blicker at Cowen Inc
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$215.00 ➝ $255.00Low
i
12/18/2019Bank of AmericaReiterated RatingBuy$220.00 ➝ $250.00Low
i
12/17/2019Morgan StanleyBoost Price TargetEqual Weight$202.00 ➝ $225.00Medium
i
12/16/2019Piper Jaffray CompaniesReiterated RatingBuy$230.00Medium
i
Rating by Matthew O'Brien at Piper Jaffray Companies
11/18/2019Piper Jaffray CompaniesReiterated RatingOverweightHigh
i
Rating by JP McKim at Piper Jaffray Companies
11/7/2019OppenheimerBoost Price Target$180.00 ➝ $205.00Medium
i
11/7/2019Canaccord GenuityBoost Price TargetBuy$185.00 ➝ $195.00High
i
11/7/2019Raymond JamesBoost Price TargetOutperform$172.00 ➝ $189.00High
i
11/7/2019Robert W. BairdBoost Price TargetOutperform$195.00 ➝ $240.00High
i
11/7/2019Jefferies Financial GroupBoost Price TargetBuy$180.00 ➝ $200.00High
i
11/7/2019JPMorgan Chase & Co.Reiterated RatingOverweight$190.00 ➝ $215.00High
i
11/7/2019GuggenheimUpgradeNeutral ➝ BuyHigh
i
10/22/2019Stifel NicolausInitiated CoverageBuy$190.00High
i
9/23/2019Piper Jaffray CompaniesSet Price TargetBuy$182.00Medium
i
Rating by JP McKim at Piper Jaffray Companies
9/3/2019BMO Capital MarketsBoost Price TargetOutperform$180.00 ➝ $190.00Low
i
8/29/2019Robert W. BairdBoost Price TargetOutperform$186.00 ➝ $195.00Low
i
8/1/2019OppenheimerBoost Price Target$167.00 ➝ $180.00Medium
i
8/1/2019Bank of AmericaBoost Price TargetBuy$162.00 ➝ $185.00Medium
i
8/1/2019Robert W. BairdBoost Price TargetOutperform$180.00 ➝ $186.00High
i
8/1/2019JPMorgan Chase & Co.Boost Price TargetOverweight$170.00 ➝ $190.00High
i
8/1/2019UBS GroupBoost Price TargetNeutral$140.00 ➝ $160.00High
i
8/1/2019Raymond JamesBoost Price TargetOutperform$150.00 ➝ $172.00High
i
8/1/2019BTIG ResearchReiterated RatingHoldHigh
i
8/1/2019Canaccord GenuityBoost Price TargetBuy$160.00 ➝ $185.00High
i
7/31/2019Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Positive$173.00 ➝ $182.00High
i
Rating by JP McKim at Piper Jaffray Companies
7/15/2019Piper Jaffray CompaniesSet Price TargetBuy$173.00High
i
Rating by JP McKim at Piper Jaffray Companies
6/6/2019Northland SecuritiesReiterated RatingHold$125.00High
i
5/2/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$167.00 ➝ $172.00High
i
5/2/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$160.00 ➝ $150.00High
i
5/1/2019Piper Jaffray CompaniesBoost Price TargetOverweight$173.00High
i
4/30/2019UBS GroupLower Price TargetNeutral ➝ Neutral$150.00 ➝ $140.00High
i
2/25/2019Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$135.00 ➝ $160.00Low
i
2/22/2019CowenBoost Price TargetOutperform$150.00 ➝ $175.00High
i
2/22/2019Canaccord GenuityBoost Price TargetBuy$140.00 ➝ $160.00High
i
1/9/2019Piper Jaffray CompaniesBoost Price TargetAverage ➝ Overweight$165.00High
i
1/8/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$135.00 ➝ $140.00Medium
i
1/2/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$150.00 ➝ $135.00High
i
12/6/2018OppenheimerSet Price TargetBuy$150.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$135.00Medium
i
11/21/2018OppenheimerReiterated RatingBuyMedium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/7/2018Jefferies Financial GroupBoost Price TargetBuy$148.00Low
i
11/7/2018StephensBoost Price TargetOverweight$170.00 ➝ $160.00Low
i
11/7/2018Piper Jaffray CompaniesBoost Price TargetOverweight$157.00Low
i
11/7/2018OppenheimerSet Price TargetBuy$150.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
10/23/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$125.00 ➝ $150.00Low
i
10/19/2018The Goldman Sachs GroupUpgradeSell ➝ Neutral$125.00High
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
10/11/2018Morgan StanleyBoost Price TargetEqual Weight$130.00 ➝ $150.00High
i
9/12/2018Northland SecuritiesUpgradeUnder Perform ➝ Market PerformHigh
i
8/23/2018Robert W. BairdBoost Price TargetOutperform ➝ Positive$140.00 ➝ $160.00Low
i
8/23/2018StephensBoost Price TargetOverweight ➝ Overweight$135.00 ➝ $160.00Low
i
8/23/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$125.00 ➝ $150.00Low
i
8/15/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$127.00 ➝ $145.00High
i
8/6/2018Berenberg BankUpgradeHold ➝ Buy$140.00Low
i
8/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $130.00Low
i
8/2/2018StephensReiterated RatingBuy$135.00Low
i
8/2/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$106.00 ➝ $127.00High
i
8/2/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$105.00 ➝ $125.00High
i
8/2/2018CowenBoost Price TargetOutperform$110.00 ➝ $120.00High
i
8/2/2018BMO Capital MarketsBoost Price TargetOutperformer ➝ Outperform$112.00 ➝ $125.00High
i
8/2/2018JPMorgan Chase & Co.Boost Price TargetOverweight$140.00High
i
Rating by Robert Marcus at JPMorgan Chase & Co.
8/2/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$115.00 ➝ $125.00High
i
8/2/2018OppenheimerSet Price TargetBuy$85.00 ➝ $125.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/2/2018Piper Jaffray CompaniesBoost Price TargetOverweight$150.00High
i
Rating by JP McKim at Piper Jaffray Companies
7/10/2018BMO Capital MarketsBoost Price TargetOutperform$112.00Low
i
7/2/2018Raymond JamesUpgradeMarket Perform ➝ OutperformMedium
i
6/28/2018Canaccord GenuityBoost Price TargetBuy$85.00 ➝ $105.00Medium
i
6/12/2018Piper Jaffray CompaniesBoost Price TargetOverweight$116.00Low
i
Rating by JP McKim at Piper Jaffray Companies
6/8/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$80.00 ➝ $115.00Medium
i
5/11/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$100.00Medium
i
5/4/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $70.00N/A
i
5/3/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$81.00 ➝ $85.00High
i
5/3/2018OppenheimerBoost Price TargetOutperform$80.00 ➝ $85.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/3/2018BMO Capital MarketsBoost Price TargetOutperformer ➝ Outperformer$78.00 ➝ $86.00High
i
5/3/2018BTIG ResearchReiterated RatingHoldHigh
i
4/9/2018StephensReiterated RatingBuy$78.00Medium
i
4/4/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$74.69 ➝ $57.00High
i
Rating by Issac Ro at The Goldman Sachs Group, Inc.
4/3/2018GuggenheimInitiated CoverageNeutral ➝ NeutralHigh
i
3/29/2018Canaccord GenuityBoost Price TargetBuy ➝ Positive$71.00 ➝ $80.00Medium
i
3/29/2018BMO Capital MarketsUpgradeOutperform$78.00Medium
i
3/29/2018OppenheimerSet Price TargetBuy$67.00 ➝ $80.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
3/29/2018Piper Jaffray CompaniesSet Price TargetBuy$80.00Medium
i
Rating by JP McKim at Piper Jaffray Companies
3/23/2018Piper Jaffray CompaniesSet Price TargetBuy$78.00High
i
Rating by JP McKim at Piper Jaffray Companies
3/23/2018Robert W. BairdUpgradeNeutral ➝ Outperform$58.00High
i
3/12/2018Piper Jaffray CompaniesReiterated RatingBuyLow
i
Rating by JP McKim at Piper Jaffray Companies
3/4/2018Northcoast ResearchReiterated RatingBuyHigh
i
Rating by E. Snyder at Northcoast Research
2/28/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$62.00 ➝ $71.00High
i
2/28/2018OppenheimerSet Price TargetBuy$67.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/26/2018Piper Jaffray CompaniesSet Price TargetBuy$60.00Low
i
Rating by JP McKim at Piper Jaffray Companies
2/12/2018OppenheimerSet Price TargetBuy$72.00 ➝ $67.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
1/16/2018Northland SecuritiesReiterated RatingSell$40.00Low
i
1/8/2018BarclaysReiterated RatingHold$60.00High
i
1/4/2018Northland SecuritiesDowngradeMarket Perform ➝ Under Perform$85.00Low
i
12/22/2017Jefferies Financial GroupBoost Price TargetTop Pick ➝ Buy$58.00 ➝ $70.00Low
i
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$74.00Medium
i
11/3/2017Morgan StanleyLower Price TargetNeutral$72.00 ➝ $52.00N/A
i
11/2/2017BarclaysLower Price TargetEqual Weight$60.00 ➝ $57.00N/A
i
11/2/2017Northland SecuritiesReiterated RatingHold$50.00N/A
i
10/4/2017WedbushReiterated RatingBuy$76.00Low
i
9/29/2017SVB LeerinkReiterated RatingBuy$85.00 ➝ $57.00High
i
9/29/2017Raymond JamesDowngradeOutperform ➝ Mkt PerformHigh
i
9/28/2017Piper Jaffray CompaniesReiterated RatingBuy$87.00High
i
9/28/2017StephensReiterated RatingBuy$83.00 ➝ $70.00High
i
9/28/2017BarclaysReiterated RatingEqual Weight$76.00 ➝ $60.00High
i
9/28/2017OppenheimerLower Price TargetOutperform$92.00 ➝ $85.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
9/28/2017Robert W. BairdLower Price TargetNeutral ➝ Neutral$79.00 ➝ $58.00High
i
9/28/2017Northland SecuritiesDowngradeOutperform ➝ Market Perform$85.00 ➝ $60.00High
i
9/28/2017CowenLower Price TargetOutperform$90.00 ➝ $64.00High
i
9/28/2017BMO Capital MarketsReiterated RatingOutperform$90.00 ➝ $62.00High
i
9/28/2017Canaccord GenuityReiterated RatingBuy$90.00 ➝ $69.00High
i
9/28/2017Raymond JamesReiterated RatingOutperform ➝ Market Perform$76.00 ➝ $49.50High
i
9/28/2017WedbushReiterated RatingOutperform ➝ Outperform$85.00 ➝ $76.00High
i
9/28/2017Jefferies Financial GroupReiterated RatingBuy$91.00High
i
9/28/2017CitigroupDowngradeOutperform ➝ Market PerformHigh
i
9/28/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$93.00 ➝ $71.00High
i
9/26/2017Northland SecuritiesInitiated CoverageOutperform ➝ Outperform$85.00Low
i
9/15/2017BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$76.00Medium
i
9/10/2017Robert W. BairdReiterated RatingHold$79.00High
i
9/8/2017BMO Capital MarketsReiterated RatingBuy$90.00High
i
9/8/2017Piper Jaffray CompaniesReiterated RatingOverweight$87.00Low
i
8/22/2017Canaccord GenuityReiterated RatingBuy$90.00Low
i
8/16/2017Piper Jaffray CompaniesReiterated RatingOverweight$87.00 ➝ $78.00Medium
i
8/8/2017BMO Capital MarketsReiterated RatingOutperform$105.00 ➝ $90.00Low
i
8/2/2017BMO Capital MarketsReiterated RatingOutperform$105.00 ➝ $90.00Low
i
8/2/2017StephensReiterated RatingOverweight$95.00 ➝ $83.00High
i
8/2/2017OppenheimerSet Price TargetBuy$98.00 ➝ $92.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
7/14/2017CowenReiterated RatingBuy$90.00Medium
i
7/13/2017BMO Capital MarketsReiterated RatingBuy$105.00Medium
i
7/12/2017Piper Jaffray CompaniesReiterated RatingBuy$78.00Low
i
6/7/2017Canaccord GenuityReiterated RatingBuy$90.00Low
i
Rating by Kyle Rose at Canaccord Genuity
5/22/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ Overweight$78.00Medium
i
5/9/2017Jefferies Financial GroupLower Price TargetBuy$91.00Low
i
5/7/2017B. RileyReiterated RatingBuy$95.00High
i
Rating by G. Chodaczek at B. Riley
5/3/2017OppenheimerSet Price TargetBuy$98.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/3/2017Canaccord GenuityLower Price TargetBuy ➝ Buy$95.00 ➝ $90.00High
i
Rating by Kyle Rose at Canaccord Genuity
5/3/2017BTIG ResearchDowngradeBuy ➝ NeutralHigh
i
5/2/2017B. RileyReiterated RatingBuy$95.00High
i
Rating by G. Chodaczek at B. Riley
4/27/2017B. RileyReiterated RatingBuy$95.00High
i
Rating by G. Chodaczek at B. Riley
4/27/2017William BlairReiterated RatingOutperformLow
i
Rating by M. Kaczor at William Blair
4/18/2017CowenReiterated RatingOutperform$90.00Low
i
4/13/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
4/4/2017Royal Bank of CanadaReiterated RatingOutperform$87.00Medium
i
3/22/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
3/6/2017B. RileyReiterated RatingBuy$95.00N/A
i
Rating by G. Chodaczek at B. Riley
3/1/2017B. RileyReiterated RatingBuy$95.00N/A
i
Rating by G. Chodaczek at B. Riley
3/1/2017Northcoast ResearchReiterated RatingBuyN/A
i
Rating by E. Snyder at Northcoast Research
3/1/2017OppenheimerSet Price TargetBuy$98.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
3/1/2017Jefferies Financial GroupBoost Price TargetBuy$80.00 ➝ $91.00N/A
i
2/18/2017B. RileyReiterated RatingBuy$94.00N/A
i
Rating by G. Chodaczek at B. Riley
2/16/2017Robert W. BairdReiterated RatingNeutral$79.00N/A
i
2/13/2017B. RileyReiterated RatingBuy$94.00N/A
i
Rating by G. Chodaczek at B. Riley
2/10/2017Canaccord GenuityReiterated RatingBuy$95.00N/A
i
Rating by Kyle Rose at Canaccord Genuity
1/23/2017Canaccord GenuitySet Price TargetBuy$95.00N/A
i
Rating by Kyle Rose at Canaccord Genuity
1/13/2017OppenheimerReiterated RatingBuy$98.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
1/13/2017BTIG ResearchReiterated RatingBuy$92.00N/A
i
1/11/2017WedbushReiterated RatingOutperform$85.00N/A
i
1/10/2017Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Kyle Rose at Canaccord Genuity
1/3/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$87.00 ➝ $66.00N/A
i
12/21/2016Canaccord GenuityReiterated RatingBuy$70.00N/A
i
Rating by Kyle Rose at Canaccord Genuity
12/20/2016B. RileyUpgradeBuy$84.00N/A
i
Rating by G. Chodaczek at B. Riley
12/19/2016OppenheimerUpgradeMarket Perform ➝ Outperform$84.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
12/19/2016UBS GroupUpgradeMarket Perform ➝ OutperformN/A
i
12/15/2016B. RileyUpgradeNeutral ➝ Buy$84.00N/A
i
Rating by G. Chodaczek at B. Riley
11/14/2016Canaccord GenuitySet Price TargetBuy$70.00N/A
i
Rating by Kyle Rose at Canaccord Genuity
11/7/2016B. RileyReiterated RatingNeutral$84.00N/A
i
11/3/2016SVB LeerinkReiterated RatingOutperform$115.00 ➝ $100.00N/A
i
11/2/2016B. RileyReiterated RatingNeutral$84.00N/A
i
11/2/2016OppenheimerSet Price TargetHold$84.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/2/2016Canaccord GenuityLower Price TargetBuy$100.00 ➝ $70.00N/A
i
11/2/2016WedbushReiterated RatingOutperform$100.00 ➝ $112.00N/A
i
10/31/2016BTIG ResearchUpgradeNeutral ➝ Buy$92.00N/A
i
10/2/2016B. RileyInitiated CoverageNeutral$97.00N/A
i
9/26/2016B. RileyInitiated CoverageNeutral$97.00N/A
i
Rating by G. Chodaczek at B. Riley
9/16/2016BMO Capital MarketsInitiated CoverageOutperform$112.00N/A
i
9/16/2016DesjardinsUpgradeHold ➝ BuyN/A
i
9/14/2016BTIG ResearchDowngradeBuy ➝ Neutral$92.00N/A
i
Rating by Sean Lavin at BTIG Research
8/4/2016Piper Jaffray CompaniesReiterated RatingOverweight$93.00 ➝ $100.00N/A
i
Rating by Brooks West at Piper Jaffray Companies
8/4/2016BTIG ResearchReiterated RatingBuy$92.00N/A
i
Rating by Sean Lavin at BTIG Research
8/3/2016JPMorgan Chase & Co.Reiterated RatingBuy$100.00N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
8/3/2016Jefferies Financial GroupReiterated RatingBuy$98.00N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
8/3/2016BenchmarkLower Price TargetBuy$106.00 ➝ $86.00N/A
i
7/22/2016Jefferies Financial GroupReiterated RatingPositive$98.00N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
7/20/2016SVB LeerinkReiterated RatingOutperform$90.00N/A
i
7/19/2016BTIG ResearchReiterated RatingBuy$92.00N/A
i
Rating by Sean Lavin at BTIG Research
7/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$93.00N/A
i
Rating by Brooks West at Piper Jaffray Companies
7/15/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$90.00 ➝ $98.00N/A
i
7/15/2016Jefferies Financial GroupReiterated RatingBuy$90.00 ➝ $98.00N/A
i
7/13/2016Canaccord GenuityReiterated RatingBuy$95.00N/A
i
6/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
6/15/2016WedbushReiterated RatingOutperform$112.00N/A
i
5/16/2016Robert W. BairdReiterated RatingHoldN/A
i
4/28/2016OppenheimerReiterated RatingHoldN/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
4/28/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by William Plovanic at Canaccord Genuity
4/14/2016BTIG ResearchInitiated CoverageBuy$80.00N/A
i
2/26/2016Raymond JamesLower Price TargetOutperform$100.00 ➝ $81.00N/A
i
2/26/2016SVB LeerinkLower Price Target$100.00 ➝ $90.00N/A
i
Rating by Danielle Antalffy at SVB Leerink LLC
2/24/2016WedbushReiterated RatingOutperform$112.00N/A
i
2/24/2016Jefferies Financial GroupBoost Price TargetBuy$90.00 ➝ $100.00N/A
i
2/24/2016JPMorgan Chase & Co.Reiterated RatingOverweight$120.00 ➝ $100.00N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
2/24/2016BenchmarkBoost Price TargetBuy$86.00 ➝ $105.00N/A
i
2/24/2016Canaccord GenuityLower Price TargetBuy$100.00 ➝ $81.00N/A
i
Rating by William Plovanic at Canaccord Genuity
2/9/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by Brooks West at Piper Jaffray Companies
2/8/2016Robert W. BairdDowngradeOutperform ➝ Neutral$100.00 ➝ $74.00N/A
i
1/12/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by William Plovanic at Canaccord Genuity
(Data available from 11/23/2015 forward)
DexCom logo
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; and a collaboration with Companion Medical, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $321.09
$314.63
$325.00

50 Day Range

MA: $369.09
$312.00
$418.00

52 Week Range

Now: $321.09
$182.07
$456.23

Volume

1,298,325 shs

Average Volume

1,260,111 shs

Market Capitalization

$30.83 billion

P/E Ratio

132.68

Dividend Yield

N/A

Beta

0.96